Name: LFMD Income Statement - Lifemd Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

LFMD - Lifemd, Inc.

USD | NASDAQ | Healthcare

LFMD Income Statement - Lifemd Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012
Revenues
Revenues	194.1	154.8	152.5	119.0	92.9	37.3	12.5	8.3	3.7	5.2	1.2	0.7	0.8	0.7
Cost of Revenue	27.7	21.4	18.9	18.7	18.0	8.9	2.5	2.0	1.0	1.9	0.2	0.2	0.2	0.2
Gross Profit	166.3	133.4	133.6	100.4	74.9	28.4	9.9	6.3	2.7	3.3	1.0	0.5	0.6	0.5
Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	0.0	-	-	-
Operating Income
Operating Income	(7.7)	(20.4)	(14.5)	(43.4)	(54.3)	(57.8)	(2.9)	(2.1)	(1.2)	(1.2)	(0.3)	(0.5)	(0.5)	(0.5)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense
Tax & Net
Income Tax Expense	0.0	0.6	0.4	0.4	0.0	0.1	(0.1)	(0.1)	-	-	-	-	-	-
Net Income From Continuing Ops
Per Share
EPS Basic	0.25	(0.60)	-	-	-	-	-	-	(0.03)	(0.03)	-	-	-	-
EPS Diluted
Supplementary Data
EBITDA	(6.8)	(19.9)	(14.3)	(43.3)	(54.3)	-	-	-	-	-	(0.2)	(0.5)	(0.5)	(0.5)
EBIT

Source: SEC EDGAR company filings. Figures as reported (US GAAP)